Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting
2020-10-22 19:30
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings
2020-10-21 19:00
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China
2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
2020-10-21 10:00
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule
2020-10-21 02:14
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
2020-10-20 19:00
Key patent granted for Isla101 in Brazil
2020-10-20 03:15
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing
2020-10-19 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference
2020-10-16 20:00
analytica 2020 - free entry from the computer
2020-10-16 17:29
Kazia Executes Agreement To Commence GBM Agile Pivotal Study
2020-10-16 07:30
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
2020-10-15 20:00
Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture
2020-10-15 11:00
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
2020-10-15 08:59
Innovent Announces the Appointment of Dr. Yong Jun Liu as the President of the Group
2020-10-15 08:00
CUREMARK Honored by Goldman Sachs for Entrepreneurship
2020-10-15 03:22
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
2020-10-14 20:00
SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan
2020-10-13 21:00
1
237
238
239
240
241
415